WeVote
Log In

Bill

Bill

HB 57

Regulation of Xylazine

2025 Regular Session Introduced by Doug Bankson and 4 co-sponsors

Florida bill to regulate xylazine as controlled substance, addressing illegal diversion into drug supplies—withdrawn during 2025 session.

Died in returning Messages
#subjectindex
0
WeVote Research Nonpartisan
Bill Summary · HB 57

Legislative bill overview

HB 57 sought to establish regulatory controls over xylazine, a veterinary tranquilizer increasingly diverted for illicit use and mixed into illicit drug supplies. The bill would have classified xylazine as a controlled substance in Florida and implemented penalties for unauthorized possession and distribution. The measure was ultimately withdrawn from consideration in the 2025 legislative session.

Why is this important

Xylazine has become a significant public health concern, frequently mixed with fentanyl and other drugs, complicating overdose treatment and creating additional addiction challenges. Classifying it as a controlled substance could provide law enforcement and public health officials clearer legal tools to address its illegal distribution and help prevent accidental poisoning deaths.

Potential points of contention

  • Legitimate veterinary use restrictions: Controlling xylazine may complicate its lawful use in veterinary medicine and could affect animal care providers' access to an established treatment option
  • Effectiveness concerns: Scheduling alone may not address the underlying supply chain diversion problem; some argue comprehensive supply-chain regulation or international controls are more effective
  • Substitution risk: Restricting one drug may simply shift illegal markets toward other veterinary or pharmaceutical tranquilizers without addressing root causes of substance misuse

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.